Literature DB >> 8747107

Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.

D Karpman1, A Andreasson, H Thysell, B S Kaplan, C Svanborg.   

Abstract

Serum and urine cytokines were analyzed in children with hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). Interleukin-6 (IL-6) was elevated in the serum of 33 of 35 children with HUS (94%) and in 2 of 2 children with recurrent TTP. Serum IL-6 was higher in children with HUS who developed anuria, extrarenal manifestations during the acute phase of illness and/or chronic renal sequelae. Tumor necrosis factor-alpha (TNF-alpha) was detected in the serum of 7 patients with HUS (20%) and 1 patient with TTP. IL-6 and TNF-alpha were elevated in the urine of 4 of 4 children with HUS and 2 of 2 children with TTP. Urinary levels were higher than serum levels, suggesting local production of cytokines in the urinary tract. Sequential serum and urine samples showed that IL-6 levels varied with disease activity. IL-6 and TNF-alpha were not detected in the serum (n = 25) and urine (n = 15) of healthy children. We conclude that IL-6 in urine may be used to monitor disease activity in HUS and TTP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8747107     DOI: 10.1007/bf00868714

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Verotoxin in thrombotic thrombocytopenic purpura.

Authors:  F Windler; H J Weh; D K Hossfeld; H R Franz; H Karch; J Heesemann; R Laufs
Journal:  Eur J Haematol       Date:  1989-01       Impact factor: 2.997

2.  Stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at various conditions.

Authors:  J Tencer; H Thysell; K Andersson; A Grubb
Journal:  Scand J Clin Lab Invest       Date:  1994-05       Impact factor: 1.713

Review 3.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).

Authors:  S Akira; T Hirano; T Taga; T Kishimoto
Journal:  FASEB J       Date:  1990-08       Impact factor: 5.191

4.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

5.  Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera.

Authors:  M Helle; L Boeije; E de Groot; A de Vos; L Aarden
Journal:  J Immunol Methods       Date:  1991-04-08       Impact factor: 2.303

6.  Plasma cytokine levels in thrombotic thrombocytopenic purpura.

Authors:  H Wada; T Kaneko; M Ohiwa; M Tanigawa; S Tamaki; N Minami; H Takahashi; K Deguchi; T Nakano; S Shirakawa
Journal:  Am J Hematol       Date:  1992-07       Impact factor: 10.047

7.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

8.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood.

Authors:  M M Fitzpatrick; V Shah; R S Trompeter; M J Dillon; T M Barratt
Journal:  Kidney Int       Date:  1992-10       Impact factor: 10.612

10.  Detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and the urinary tract.

Authors:  K Ohta; N Takano; A Seno; A Yachie; T Miyawaki; H Yokoyama; N Tomosugi; E Kato; N Taniguchi
Journal:  Clin Nephrol       Date:  1992-10       Impact factor: 0.975

View more
  29 in total

1.  Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome.

Authors:  Tiffany R Keepers; Lisa K Gross; Tom G Obrig
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

2.  Hemolytic uremic syndrome in an infant following Bordetella pertussis infection.

Authors:  I Pela; D Seracini; A Caprioli; F Castelletti; A Giammanco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

Review 3.  Advances in haemolytic uraemic syndrome.

Authors:  C M Taylor; L A Monnens
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

4.  Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection.

Authors:  C D Inward; M Varagunam; D Adu; D V Milford; C M Taylor
Journal:  Arch Dis Child       Date:  1997-08       Impact factor: 3.791

Review 5.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

6.  Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue.

Authors:  Teresa M DesRochers; Erica Palma Kimmerling; Dakshina M Jandhyala; Wassim El-Jouni; Jing Zhou; Cheleste M Thorpe; John M Leong; David L Kaplan
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

7.  Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.

Authors:  C M Thorpe; B P Hurley; L L Lincicome; M S Jacewicz; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 8.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.

Authors:  Anne-lie Ståhl; Lisa Sartz; Anders Nelsson; Zivile D Békássy; Diana Karpman
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

10.  Enhanced CXC chemokine responses of human colonic epithelial cells to locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli.

Authors:  Trisha J Rogers; Adrienne W Paton; Shaun R McColl; James C Paton
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.